RZLT
Rezolute, Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.58
+0.88%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-69.7%
Return on equity
-64.9%
Return on assets
-74.0%
Return on invested capital
0.00x
Asset turnover
-$73.5M
Cash from operations
$1.25
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026